The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PET
Abstract
OBJECTIVE: A positron emission tomography (PET) study has suggested that dopamine transporter density of the caudate/putamen is reduced in methamphetamine users. The authors measured nucleus accumbens and prefrontal cortex density, in addition to caudate/putamen density, in methamphetamine users and assessed the relation of these measures to the subjects' clinical characteristics. METHOD: PET and 2-beta-carbomethoxy-3beta-(4-[(11)C] fluorophenyl)tropane, a dopamine transporter ligand, were used to measure dopamine transporter density in 11 male methamphetamine users and nine male comparison subjects who did not use methamphetamine. Psychiatric symptoms in methamphetamine users were evaluated by using the Brief Psychiatric Rating Scale and applying a craving score. RESULTS: The dopamine transporter density in all three of the regions observed was significantly lower in the methamphetamine users than the comparison subjects. The severity of psychiatric symptoms was significantly correlated with the duration of methamphetamine use. The dopamine transporter reduction in the caudate/putamen and nucleus accumbens was significantly associated with the duration of methamphetamine use and closely related to the severity of persistent psychiatric symptoms. CONCLUSIONS: These findings suggest that longer use of methamphetamine may cause more severe psychiatric symptoms and greater reduction of dopamine transporter density in the brain. They also show that the dopamine transporter reduction may be long-lasting, even if methamphetamine use ceases. Further, persistent psychiatric symptoms in methamphetamine users, including psychotic symptoms, may be attributable to the reduction of dopamine transporter density.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
The behavioural and motor consequences of focal lesions of the basal ganglia in man
Bhatia, K. P., & Marsden, C. D. (1994) · Brain · doi:10.1093/brain/117.4.859 · Cited by 1,073
Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G., Anthony, R. M., Schmunk, G. A., Shannak, K., Haycock, J. W., & Kish, S. J. (1996) · Nature Medicine · doi:10.1038/nm0696-699 · Cited by 718
Andreasen, N. C., O'Leary, D. S., Cizadlo, T., Arndt, S., Rezai, K., Ponto, L. L., Watkins, G. L., & Hichwa, R. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9985 · Cited by 625
McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08417.1998 · Cited by 602
Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.
Hastings, T. G., Lewis, D. A., & Zigmond, M. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1956 · Cited by 547
Effects of chronic cocaine abuse on postsynaptic dopamine receptors
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.6.719 · Cited by 421
Localization of drug reward mechanisms by intracranial injections
Wise, R. A., & Hoffman, D. C. (1992) · Synapse · doi:10.1002/syn.890100307 · Cited by 275
Cook, C. E., Jeffcoat, A. R., Hill, J. M., Pugh, D. E., Patetta, P. K., Sadler, B. M., White, W. R., & Perez-Reyes, M. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07478-1 · Cited by 263
Dopamine transporters decrease with age.
Volkow, N. D., Ding, Y., Fowler, J. S., Wang, G., Logan, J., Gatley, S. J., Hitzemann, R., Smith, G., Fields, S. D., & Gur, R. C. (1996) · PubMed · Cited by 262
Iyo, M., Namba, H., Fukushi, K., Shinotoh, H., Nagatsuka, S., Suhara, T., Sudo, Y., Suzuki, K., & Irie, T. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09124-6 · Cited by 259
Self-citationPsychiatric syndromes in Huntington’s disease.
(1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.6.728 · Cited by 255
Relapse of Paranoid Psychotic State in Methamphetamine Model of Schizophrenia
Sato, M., Numachi, Y., & Hamamura, T. (1992) · Schizophrenia Bulletin · doi:10.1093/schbul/18.1.115 · Cited by 221
Villemagne, V., Yuan, J., Wong, D. F., Dannals, R. F., Hatzidimitriou, G., Mathews, W. B., Ravert, H. T., Musachio, J., McCann, U. D., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00419.1998 · Cited by 211
Farde, L., Pauli, S., Hall, H., Eriksson, L., Halldin, C., H�gberg, T., Nilsson, L., Sj�gren, I., & Stone-Elander, S. (1988) · Psychopharmacology · doi:10.1007/bf00212840 · Cited by 200
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.2.174 · Cited by 182
Modification of Dopamine Transporter Function: Effect of Reactive Oxygen Species and Dopamine
Berman, S. B., Zigmond, M. J., & Hastings, T. G. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020593.x · Cited by 179
Benedetti, F., Serretti, A., Colombo, C., Campori, E., Barbini, B., di Bella, D., & Smeraldi, E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1450 · Cited by 167
PET Imaging of Serotonin Type 2A Receptors in Late-Life Neuropsychiatric Disorders
Meltzer, C. C., Price, J. C., Mathis, C. A., Greer, P. J., Cantwell, M. N., Houck, P. R., Mulsant, B. H., Ben-Eliezer, D., Lopresti, B., DeKosky, S. T., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1871 · Cited by 163
Melchitzky, D. S., & Lewis, D. A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00139-6 · Cited by 149
Ouchi, Y., Yoshikawa, E., Okada, H., Futatsubashi, M., Sekine, Y., Iyo, M., & Sakamoto, M. (1999) · PubMed · Cited by 145
Self-citationPsychophysiological Aspects of Amphetamine-Methamphetamine Abuse
Murray, J. B. (1998) · The Journal of Psychology · doi:10.1080/00223989809599162 · Cited by 140
Tissingh, G., Booij, J., Bergmans, P., Winogrodzka, A., Janssen, A. G. M., van Royen, E. A., Stoof, J. C., & Wolters, E. C. (1998) · PubMed · Cited by 140
Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan
Iwanami, A., Sugiyama, A., Kuroki, N., Toda, S., Kato, N., Nakatani, Y., Horita, N., & Kaneko, T. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01541.x · Cited by 135
Brain dopamine transporter: gender differences and effect of chronic haloperidol
Rivest, R., Falardeau, P., & Paolo, T. D. (1995) · Brain Research · doi:10.1016/0006-8993(95)00611-s · Cited by 123
Bromocriptine in the prevention of alcohol abuse
Borg, V. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb06987.x · Cited by 99
Poole, R., & Brabbins, C. (1996) · The British Journal of Psychiatry · doi:10.1192/bjp.168.2.135 · Cited by 89
Dopaminomimetic psychosis in Parkinson's disease patients: diagnosis and treatment.
Wolters, E. C. (1999) · PubMed · Cited by 78
Amphetamine use: return of an old scourge in a consultation psychiatry setting
Baberg, H. T., Nelesen, R. A., & Dimsdale, J. E. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.6.789 · Cited by 67
Prediction of Detached Personality in Healthy Subjects by Low Dopamine Transporter Binding
Laakso, A., Vilkman, H., Kajander, J., Bergman, J. R., Haaparanta‐Solin, M., Solin, O. H., & Hietala, J. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.290 · Cited by 66
Human Methamphetamine-Related Fatalities in Taiwan During 1991–1996
Shaw, K.-P. (1999) · Journal of Forensic Sciences · doi:10.1520/jfs14408j · Cited by 61
Chronic Psychotic Illness From Methamphetamine
Buffenstein, A., HEASTER, J., & KO, P. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.662 · Cited by 60
Mechanisms of Biogenic Amine Neurotransmitter Transporters
Rudnick, G. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-158-9_2 · Cited by 58
Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs
Allard, P. O., Eriksson, K., Ross, S. B., & Marcusson, J. O. (1990) · Psychopharmacology · doi:10.1007/bf02244092 · Cited by 57
Development of a high resolution PET
Yamashita, T., Uchida, H., Okada, H., Kurono, T., Takemori, T., Watanabe, M., Shimizu, K., Yoshikawa, E., Ohmura, T., Satoh, N., et al. (1990) · IEEE Transactions on Nuclear Science · doi:10.1109/23.106683 · Cited by 45
Self-citationIyo, M., Nishio, M., Itoh, T., Fukuda, H., Suzuki, K., Yamasaki, T., Fukui, S., & Tateno, Y. (1993) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(93)90002-y · Cited by 34
Self-citationMohr, P., Horáček, J., Motlová, L. B., Libiger, J., & Czobor, P. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00124-2 · Cited by 27
Methamphetamine-Associated Obsessional Symptoms and Effective Risperidone Treatment: A Case Report
Iyo, M., Sekine, Y., Matsunaga, T., Tsukamoto, T., Takei, N., & Mori, N. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0512d · Cited by 17
Self-citation
Cited by
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001507 · Cited by 1,101
A review of the clinical pharmacology of methamphetamine
Cruickshank, C. C., & Dyer, K. R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 769
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine
Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M. S., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W., & London, E. D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 760
Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 671
Psychiatric Symptoms in Methamphetamine Users
Zweben, J. E., Cohen, J. B., Christian, D., Galloway, G. P., Salinardi, M., Parent, D., Iguchi, M., & Methamphetamine Treatment Project (2004) · The American Journal on Addictions · doi:10.1080/10550490490436055 · Cited by 468
Metadata
- Authors
- Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, M., Takei, N., & Mori, N.
- Venue
- American Journal of Psychiatry
- Published
- 2001-08-01
- Volume
- 158
- Issue
- 8
- Pages
- 1206-1214
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2014488168
- Cited by
- 406
- References
- 40
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.